New proton therapy software tool

Proton therapy is very sophisticated way of destroying tumours. Now the Swedish Medical company RaySearch Laboratories has signed a consulting agreement with Uppsala University Hospital in Sweden to develop a treatment-planning system.

Proton therapy device at the TSL.
Proton therapy device at the TSL.

Proton therapy might be the last chance option for patients suffering on tumours which grow deep in the body or are surrounded by very sensitive organs. Protons offer optimised dose distribution within the targeted region. The accelerator speeds up the protons to 60 per cent of light speed and leads the beam precisely to the tumour, where the protons damage the cells and particularly their DNA.

The Svedberg Laboratory (TSL), a proton therapy facility run by the Uppsala University, treats more than 100 cancer patients annually with protons. “To capitalize on the advantages of proton-therapy, which is more precise than conventional radiation therapy, a reliable and accurate dose calculation is of extra importance”, said Ulf Isacsson, responsible for radiation therapy at the Hospital Physics department of the University Hospital. “This will be provided by this system from RaySerch.”

Proton therapy is one of its priority development areas. Its concept include the optimization of scanned beams calculated with a proprietary Monte Carlo algorithm, a joint development with Nucletron from the Netherlands.

The Swedish hospital was the first in the world to treat cancer tumours with protons. For RaySearch the agreement has no direct financial impact, but it is of high strategic importance “that our proton system will now be used clinically for the first time.”


Read all latest stories

Related articles


IBA cooperates with Philips to create proton therapy centers

IBA Group, a leader in advanced cancer diagnosis and therapy technologies and Royal Philips Electronics, announced they have entered into an agreement to create state of the art patient-centric…


Proton therapy

As one of the most advanced forms of precision radiotherapy, proton therapy enables the irradiation of tumours located deep within the body, in the proximity of critical organs, such as the optic…


ECCO 15 and 34th ESMO Multidisciplinary Congress unites European Oncology

The first joint congress ECCO 15 - ESMO 34 of the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO) is taking place this week in Berlin. It is the only…

Related products

Beckman Coulter – Prostate Health Index (phi)


Beckman Coulter – Prostate Health Index (phi)

Beckman Coulter, Inc.
Subscribe to Newsletter